Dual Study First to Suggest Genetic Basis for Personalized Adjunctive Tuberculosis Treatment
February 22, 2012
Dual Study First to Suggest Genetic Basis for Personalized Adjunctive Tuberculosis Treatment
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter - Study Finds Dopamine Gene Variant Predictive of Placebo Response in IBS Patients
October 24, 2012 / Pharmacogenomics Reporter - Genome BC Funds $9.8M Project to Identify Subgroups in Medulloblastoma for Personalized Treatment
February 15, 2012 / Pharmacogenomics Reporter - Mayo Study Highlights How Concurrent NSCLC Mutations May Complicate Genetic Testing Strategies
April 24, 2013 / Pharmacogenomics Reporter - MDxHealth and Ghent University Begin Collaboration under New Pharmacoepigenomics Center
December 12, 2012 / Pharmacogenomics Reporter